with Hardeep Singh Tuli (author)

This book describes the translational approach to cancer treatment and the progression from clinical and molecular diagnoses to treatments. Additionally, genetic changes, microRNAs, and long non-coding RNAs contribute to the precision of medicine for individualized treatment of patients with cancer. It describes the involvement of various genetic factors in the pharmacodynamic/pharmacokinetic (PD/PK) changes of drugs. In fact, the role of bioinformatics and biostatistics, considering the extensive data analysis that serves the precision medicine approach, has been considered in this book as well. As a result, the intended book’s successes in demonstrating the effective medical evidence for the utilization of precision medicine in the treatment of cancer and its potential for future clinical application. It填补s the gaps in cancer biology and precision medicine with its current content and effective sections. It will be a significant resource for the science, medical students, and interdisciplinary researchers. It’s a welcome addition to the scientific community, research centers, and university-industry collaborators. They will find out all about the capsular package of cancer drugs, the precision of the process, and the personalized nature of medicine (including an introduction to the way cancer cells signal, alter their genomes, and target miRNAs in precision medicine, among other things). This information will be available at a single platform.

Authors: The journal is published by Springer Nature Singapore; it was released on July 8th, 2023.

Speakers: English

ISBN: 9789819915286

ISBN: 9789819915293